Philip Isham serves as Chief Development Officer at Eye Health America™ In this role, Isham is responsible for the formulation of Eye Health America’s business development strategy and execution of the organization’s M&A and organic business growth goals.
Isham brings 30 years of industry experience spanning from direct customer engagement to senior executive roles. He is recognized as both an industry and thought leader within eye care, holding multiple positions within organizations such as Merck & Co., NCI Consulting, and Allergan. He also serves as Principal and Executive Consultant at ECP Advisor Group.
Over his career, Isham has been responsible for designing the strategic framework, recruiting, and successful execution of nationally based consulting programs, educational offerings, and the development of various new business initiatives in healthcare. His innovative approach and guidance to his clients has led to successful business outcomes such as enterprise growth and M&A transactions with private equity groups.
Isham is a frequent speaker and educator at many ophthalmology conferences across the country. He earned his Bachelor of Arts degree in Biology from The University of Texas at Austin.